Page last updated: 2024-11-07

tuliposide a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tuliposide A: RN given refers to (beta-D-Glucopyranose); RN for cpd without isomeric designation not available 2/90; found in the Alstroemeria plant [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AlstroemeriagenusA plant genus of the family Alstroemeriaceae. Members contain allergens, tuliposide A and tulipalin A.[MeSH]AlstroemeriaceaeA family of the order Liliales.[MeSH]

Cross-References

ID SourceID
PubMed CID108011
CHEMBL ID1255769
CHEBI ID9777
MeSH IDM0172989

Synonyms (13)

Synonym
19870-30-5
tuliposide a
C08561
AR-1L8666 ,
[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 4-hydroxy-2-methylidenebutanoate
AC1L3362 ,
chebi:9777 ,
CHEMBL1255769 ,
1-tuliposide a
beta-d-glucopyranose, 1-(4-hydroxy-2-methylenebutanoate)
DTXSID20941709
1-o-(4-hydroxy-2-methylidenebutanoyl)hexopyranose
Q27108493
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
O-acyl carbohydrateA carbohydrate derivative in which the hydrogen atom of at least one alcoholic hydroxy group of a carbohydrate has been replaced by an acyl substituent.
homoallylic alcoholAn aliphatic alcohol where the hydroxy carbon is beta to a double bond.
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID516575Inhibition of Escherichia coli MurA2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
AID516577Inhibition of Escherichia coli MurA C115D mutant at 25 uM2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
AID516842Antimicrobial activity against Escherichia coli BL21 assessed as growth inhibition at 200 uM in presence of minimum medium2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
AID516578Antimicrobial activity against Escherichia coli BL21 assessed as growth inhibition at 200 uM after 24 hrs2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
AID516576Inhibition of Escherichia coli MurA at 25 uM2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (64.29)18.2507
2000's0 (0.00)29.6817
2010's5 (35.71)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.91 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (21.43%)4.05%
Observational0 (0.00%)0.25%
Other11 (78.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]